2024
DOI: 10.1111/febs.17044
|View full text |Cite
|
Sign up to set email alerts
|

SLC35A2 expression drives breast cancer progression via ERK pathway activation

Xiaochen Yang,
Yukai Tao,
Yan Xu
et al.

Abstract: Alterations in glycosylation are associated with breast tumor formation and progression. Nevertheless, the specific functions and mechanisms of the human major UDP‐galactose transporter‐encoding gene Solute carrier family 35 member A2 (SLC35A2) in breast invasive carcinoma (BRCA) have not been fully determined. Here we reportthat SLC35A2promotesBRCA progression via activating ERK. SLC35A2 expression and prognosis‐predictive significance in pan‐cancer were evaluated using publicdatabases. The upstream non‐codin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 75 publications
0
0
0
Order By: Relevance